Smrdel U - Search Results

1

Cognitive functioning is prognostic in patients with IDH1-wild type and MGMT-unmethylated high-grade gliomas.

Smrdel U, Škufca Smrdel AC, Podlesek A, Skoblar Vidmar M, Kos G, Markovic J, Jereb J, Knific J, Rus T. Smrdel U, et al. Croat Med J. 2023 Dec 31;64(6):383-390. doi: 10.3325/cmj.2023.64.383. Croat Med J. 2023. PMID: 38168519 Free PMC article.

2

Cognitive functioning in a cohort of high-grade glioma patients.

Skufca Smrdel AC, Podlesek A, Skoblar Vidmar M, Markovic J, Jereb J, Okorn MK, Smrdel U. Skufca Smrdel AC, et al. Among authors: smrdel u. Radiol Oncol. 2023 Jun 21;57(2):201-210. doi: 10.2478/raon-2023-0009. eCollection 2023 Jun 1. Radiol Oncol. 2023. PMID: 37341199 Free PMC article.

3

The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers.

Skoblar Vidmar M, Doma A, Smrdel U, Zevnik K, Studen A. Skoblar Vidmar M, et al. Among authors: smrdel u. Int J Mol Sci. 2022 Jun 17;23(12):6787. doi: 10.3390/ijms23126787. Int J Mol Sci. 2022. PMID: 35743228 Free PMC article.

4

Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor.

Smrdel U, Popovic M, Zwitter M, Bostjancic E, Zupan A, Kovac V, Glavac D, Bokal D, Jerebic J. Smrdel U, et al. Radiol Oncol. 2016 Nov 10;50(4):394-401. doi: 10.1515/raon-2015-0041. eCollection 2016 Dec 1. Radiol Oncol. 2016. PMID: 27904447 Free PMC article.

5

Glioblastoma patients in Slovenia from 1997 to 2008.

Smrdel U, Kovac V, Popovic M, Zwitter M. Smrdel U, et al. Radiol Oncol. 2014 Jan 22;48(1):72-9. doi: 10.2478/raon-2014-0002. eCollection 2014 Mar. Radiol Oncol. 2014. PMID: 24587783 Free PMC article.

6

Glioblastoma in Patients over 70 Years of Age.

Smrdel U, Vidmar MS, Smrdel A. Smrdel U, et al. Radiol Oncol. 2018 Feb 25;52(2):167-172. doi: 10.2478/raon-2018-0010. eCollection 2018 Jun. Radiol Oncol. 2018. PMID: 30018520 Free PMC article.

7

Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: a phase II randomized trial.

Zwitter M, Kovac V, Rajer M, Vrankar M, Smrdel U. Zwitter M, et al. Among authors: smrdel u. Anticancer Drugs. 2010 Jul;21(6):662-8. doi: 10.1097/CAD.0b013e32833ab7a0. Anticancer Drugs. 2010. PMID: 20453635 Clinical Trial.

8

Gemcitabine in brief versus prolonged low-dose infusion, both combined with cisplatin, for advanced non-small cell lung cancer: a randomized phase II clinical trial.

Zwitter M, Kovac V, Smrdel U, Vrankar M, Zadnik V. Zwitter M, et al. Among authors: smrdel u. J Thorac Oncol. 2009 Sep;4(9):1148-55. doi: 10.1097/JTO.0b013e3181ae280f. J Thorac Oncol. 2009. PMID: 19546818 Free article. Clinical Trial.

9

Intermittent chemotherapy and erlotinib for nonsmokers or light smokers with advanced adenocarcinoma of the lung: a phase II clinical trial.

Zwitter M, Rajer M, Kovac V, Kern I, Vrankar M, Smrdel U. Zwitter M, et al. Among authors: smrdel u. J Biomed Biotechnol. 2011;2011:185646. doi: 10.1155/2011/185646. Epub 2011 Apr 12. J Biomed Biotechnol. 2011. PMID: 21541241 Free PMC article. Clinical Trial.

10

Meta-analyses of clinical trials in patients with non-small cell lung cancer. Minireview.

Kovac V, Smrdel U. Kovac V, et al. Among authors: smrdel u. Neoplasma. 2004;51(5):334-40. Neoplasma. 2004. PMID: 15640936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page